Skip to main content
Clinical Trials/IRCT2013022712644N1
IRCT2013022712644N1
Completed
Phase 2

The Comparison of the effects of hyaluronic acid and conjugated estrogen vaginal cream (Prmarin) on vaginal atrophy in menopausal women referred to selected clinics affiliated to Shiraz university of medical sciences, 1391

Vice chancellor for research Shiraz University of Medical Sciences0 sites56 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Vaginal atrophy.
Sponsor
Vice chancellor for research Shiraz University of Medical Sciences
Enrollment
56
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chancellor for research Shiraz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Major inclusion criteria: Married women past menopause who have symptoms?Non\-Smoking? The use of drugs such as Heparin anticoagulants? Vaginal dryness and moderate to severe pain in the area during intercourse. (measured by visual criteria)? Do not use vaginal medications, hormonal and non\-hormonal treatment for 30 days before? No history of known or suspected hormone\-dependent diseases such as (breast cancer, cases of unexplained vaginal bleeding, acute Phlebitis or Thromboembolic disorders associated with estrogen and ...)
  • Major exclusion criteria: Need to cure vaginal infection in primary screening for Pap smear? Sensitivity (rash, erythema, inflammation, ...) to the drug or its ingredients? Lack of desire to continue working

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials